Need professional-grade analysis? Visit stockanalysis.com
$42.86M
N/A
N/A
N/A
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $1.13, up 2.73% from the previous close.
Over the past year, MIRA has traded between a low of $0.92 and a high of $2.02. The stock has gained 13.7% over this period. It is currently 44.1% below its 52-week high.
MIRA Pharmaceuticals, Inc. Common Stock has a market capitalization of $42.86M.
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
Side-by-side comparison against top Healthcare peers.